State of Wisconsin Investment Board’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$130K Buy
+28,796
New +$115K ﹤0.01% 2400
2025
Q3
Sell
-31,515
Closed -$91.1K 2458
2025
Q2
$91.1K Sell
31,515
-56,012
-64% -$130K ﹤0.01% 2277
2025
Q1
$188K Buy
87,527
+29,569
+51% +$93.5K ﹤0.01% 2114
2024
Q4
$224K Buy
57,958
+18,373
+46% +$121K ﹤0.01% 2114
2024
Q3
$259K Buy
+39,585
New +$318K ﹤0.01% 2090
2019
Q2
Sell
-3,425
Closed -$113K 1573
2019
Q1
$113K Buy
3,425
+783
+30% +$40.1K ﹤0.01% 1500
2018
Q4
$157K Buy
2,642
+667
+34% +$65.8K ﹤0.01% 1469
2018
Q3
$277K Buy
+1,975
New +$240K ﹤0.01% 1476

Other funds holding LRMR

State of Wisconsin Investment Board's LRMR Position: Q1 2026 in Review

State of Wisconsin Investment Board opened a new position in Larimar Therapeutics (LRMR) in Q1 2026: 28,796 shares worth $130K. The stake represents ﹤0.01% of the portfolio and ranks #2400 among its holdings. This is a return to the name: State of Wisconsin Investment Board previously reported a position in LRMR as recently as Q2 2025.

State of Wisconsin Investment Board first reported a position in LRMR in Q3 2018 and has held it in 8 quarters since. The position peaked at $277K in Q3 2018. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • State of Wisconsin Investment Board held 28,796 shares of Larimar Therapeutics worth $130K as of Q1 2026.
  • Larimar Therapeutics was a new State of Wisconsin Investment Board position in Q1 2026.
  • Larimar Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #2400 holding.
  • State of Wisconsin Investment Board first reported a position in Larimar Therapeutics in Q3 2018 and has held it in 8 quarters since.
  • State of Wisconsin Investment Board's Larimar Therapeutics position peaked at $277K in Q3 2018.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.